Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... symptoms if they try to quit. The withdrawal symptoms contribute to the relapse and maintenance of marijuana use. Withdrawal symptoms are similar to those experienced by people who ... ingesting a capsule, using a spray inhaler, or smoking marijuana. The patch will reduce dosing frequency and is expected to improve marijuana withdrawal and addiction symptoms, ...
2009 NOV 1 ... beginning 2 hours after irradiation at 20 and 40 mg/kg loading dose followed by a maintenance dose of half the loading dose given 3 times per week for 4 weeks. Animals received 15 Gy ... this study will be used in the second two parts of the Duke study which will look at dosing, duration of treatment and the maximum length of time after exposure that the drug can ...
2009 NOV 16 ... sugar levels before additional treatment is initiated. Initial combination therapy or maintenance of combination therapy may not be appropriate for all patients. These management options ... risk reduction with JANUMET or any other oral anti-diabetic drug. Dosing of JANUMET JANUMET is available as sitagliptin/metformin 50/500 mg and ...
2009 NOV 9 ... 400mg at Weeks 0, 2 and 4. In patients who obtain a clinical response, the recommended maintenance regimen is 400 mg every four weeks. In the WELCOME trial, which evaluated ... weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the ...
2009 NOV 9 ... induction phase were randomized to receive CIMZIA or placebo and evaluated for maintenance of clinical response by week 26, of which a significant majority (62 percent) of CIMZIA ... Grips® for subcutaneous self-administration once every four weeks after initial dosing. CIMZIA, manufactured by UCB, was approved by the U.S. Food and Drug Administration on ...
2009 NOV 9 ... induction phase were randomized to receive CIMZIA or placebo and evaluated for maintenance of clinical response by week 26, of which a significant majority (62 percent) of CIMZIA ... Good Grips=AE for subcutaneous self-administration once every four weeks after initial dosing. CIMZIA, manufactured by UCB, was approved by the U.S. Food and Drug Administration on ...
2009 NOV 2 ... to a study from the United States, "Sitagliptin is recommended for initial and maintenance dosing at 100 mg daily." "Downward dose adjustment is recommended in patients ...
2009 NOV 23 ... (2.4 g/day, once daily), compared with Asacol ® (2.4 g/day, twice daily) in the maintenance of left-sided UC, through a double-blind, double-dummy, parallel-group, randomized, ... ® (1.2 g/tablet) is a 5-aminosalicylic acid formulation, designed for once-daily dosing in the treatment of ulcerative colitis. To evaluate the efficacy and safety of 5-ASA-MMX ...
2009 NOV 9 ... GERD, for the short-term treatment of erosive esophagitis diagnosed by endoscopy, for maintenance of healing of erosive esophagitis (controlled studies do not extend beyond 12 months), ... to 18.6 hours, depending on the strength and dosage form, after repeated once-daily dosing. ZEGERID can be conveniently taken once-a-day on an empty stomach, at least one hour ...
2009 OCT 19 ... on ulcerative colitis are presented in the report 'Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with ... (1.2 g/tablet) is a 5-aminosalicylic acid formulation, designed for once-daily dosing in the treatment of ulcerative colitis. To evaluate the efficacy and safety of 5-ASA-MMX ...
2009 NOV 9 ... of 400 mg at weeks 0, 2, and 4 followed by 200 mg every 2 weeks, or an alternative maintenance regimen of 400 mg every 4 weeks." Lacroix and colleagues published their ... concluded: "Data from simulations of the ACR20 response rate support the use of dosing regimens of 400 mg at weeks 0, 2, and 4 followed by 200 mg every 2 weeks, or an ...
2009 NOV 1 ... were determined by Bayesian forecasting for 45 Japanese patients." "Maintenance doses were described by multiple linear regression using individually estimated PK/PD ... PK/PD parameters and INR values. The validity of the model and a comparison with other dosing methods were evaluated by bootstrap resampling and a cross-validation method. The plasma ...
2009 NOV 16 ... Diego, Oct. 23-28. Rifaximin Has a Favorable Long-Term Safety Profile for Maintenance of Remission from Overt Hepatic Encephalopathy Oral 54, Wed, Oct. 28, 8:30 ... double-blind, placebo-controlled trials (RCT) and treated for six months with once-daily dosing of 1.5 g granulated mesalamine and then rolled over into a 24-month open label extension ...
2009 NOV 23 ... the FDA accepted for filing our New Drug Application for rifaximin 550mg tablets for the maintenance of remission of hepatic encephalopathy and also announced that the NDA had been ... 2mg/25mL budesonide foam dosed twice-a-day (BID) for 2 weeks followed by once-a-day (QD) dosing for 4 weeks, versus placebo foam. Each study is targeted to enroll approximately 430 ...
2009 NOV 9 ... "Vardenafil is reported to improve success rates in the maintenance of an erection sufficient for completion of intercourse (SEP-3) compared with placebo in ... dysfunction (ED) patients who attempted intercourse from as early as 15 minutes after dosing. However, these data were based on general ED patients, using time from administration ...
2009 NOV 9 ... of Neuroscience (Neuropathy Target Esterase Is Required for Adult Vertebrate Axon Maintenance. Journal of Neuroscience, 2009;29(37):11594-11600). For additional ... in similar to 3-week-old nestin-cre:NTEfl/fl mice and in adult C57BL/6J mice after acute dosing with a neuropathic organophosphate: in both groups early degenerative lesions were ...
2009 NOV 9 ... for the observation arm, and 0.62 and 0.59 (0.50, 0.65), respectively, for the rituximab maintenance arm. For rituximab monotherapy, observed and predicted PFS at 24 months were 0.67 and ... improved the survival of patients with non-Hodgkin's lymphomas (NHL), but the dosing regimen currently used should be optimized. However, the concentration-effect ...
2009 NOV 2 ... dosed at 400 mg initially and at weeks 2 and 4, followed by 200 mg every other week; for maintenance dosing, 400 mg every 4 weeks can be considered. Also presented at the Annual ...
